Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Diemberger

Showing results (201-210 of 238) with videos related to

Pageof 24
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|August 4, 2025
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and strokeDavide Antonio Mei, Giulio Francesco Romiti, Marco Vitolo, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2017
Use of azithromycin and risk of ventricular arrhythmiaGianluca Trifirò, Maria de Ridder, Janet Sultana, et al.
International Journal of Cardiology. Heart & Vasculature|December 6, 2024
From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillationStefano Fumagalli, Giulia Ricciardi, Claudia Di Serio, et al.
The American Journal of Medicine|February 4, 2014
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot surveyGregory Y H Lip, Cécile Laroche, Gheorghe-Andrei Dan, et al.
Revista Espanola De Cardiologia (English Ed.)|August 15, 2025
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohortMarco Vitolo, Marco Proietti, Marta Mantovani, et al.
Heart Rhythm|June 1, 2019
Time to therapy delivery and effectiveness of the subcutaneous implantable cardioverter-defibrillatorIgor Diemberger, Federico Migliore, Giuseppe Ricciardi, et al.
European Journal of Internal Medicine|October 1, 2025
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registryDavide Antonio Mei, Jacopo Francesco Imberti, Marco Vitolo, et al.
European Journal of Clinical Investigation|March 19, 2022
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registryVincenzo L Malavasi, Marco Vitolo, Marco Proietti, et al.
European Journal of Internal Medicine|February 18, 2022
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registryMarco Vitolo, Vincenzo L Malavasi, Marco Proietti, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 21, 2025
Pulsed field ablation for paroxysmal supraventricular tachycardia: a systematic review and single-arm meta-analysisGiang Son Arrighini, Mrunalini Dandamudi, Vinh Quang Tri Ho, et al.
Pageof 24

Showing results (201-210 of 238) with videos related to

Sort By:
Pageof 24
European Heart Journal. Quality of Care & Clinical Outcomes|August 4, 2025
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and strokeDavide Antonio Mei, Giulio Francesco Romiti, Marco Vitolo, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2017
Use of azithromycin and risk of ventricular arrhythmiaGianluca Trifirò, Maria de Ridder, Janet Sultana, et al.
International Journal of Cardiology. Heart & Vasculature|December 6, 2024
From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillationStefano Fumagalli, Giulia Ricciardi, Claudia Di Serio, et al.
The American Journal of Medicine|February 4, 2014
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot surveyGregory Y H Lip, Cécile Laroche, Gheorghe-Andrei Dan, et al.
Revista Espanola De Cardiologia (English Ed.)|August 15, 2025
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohortMarco Vitolo, Marco Proietti, Marta Mantovani, et al.
Heart Rhythm|June 1, 2019
Time to therapy delivery and effectiveness of the subcutaneous implantable cardioverter-defibrillatorIgor Diemberger, Federico Migliore, Giuseppe Ricciardi, et al.
European Journal of Internal Medicine|October 1, 2025
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registryDavide Antonio Mei, Jacopo Francesco Imberti, Marco Vitolo, et al.
European Journal of Clinical Investigation|March 19, 2022
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registryVincenzo L Malavasi, Marco Vitolo, Marco Proietti, et al.
European Journal of Internal Medicine|February 18, 2022
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registryMarco Vitolo, Vincenzo L Malavasi, Marco Proietti, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 21, 2025
Pulsed field ablation for paroxysmal supraventricular tachycardia: a systematic review and single-arm meta-analysisGiang Son Arrighini, Mrunalini Dandamudi, Vinh Quang Tri Ho, et al.
Pageof 24